E-LIB Suche - Ergebnisse für: Courtin, Aurélie

1

Discovery of ASTX029, A Clinical Candidate Which Modulates ..:

Heightman, Tom D. ; Berdini, Valerio ; Bevan, Luke...
Journal of Medicinal Chemistry. 64 (2021) 16 - p. 12286-12303 , 2021

Link: https://doi.org/10.1021/..

2

Fragment-Based Discovery of a Potent, Orally Bioavailable I..:

Heightman, Tom D. ; Berdini, Valerio ; Braithwaite, Hannah...
Journal of Medicinal Chemistry. 61 (2018) 11 - p. 4978-4992 , 2018

Link: https://doi.org/10.1021/..

3

Quantitation of ERK1/2 inhibitor cellular target occupancie..:

Lebraud, Honorine ; Surova, Olga ; Courtin, Aurélie...
Chemical Science. 9 (2018) 45 - p. 8608-8618 , 2018

Link: https://doi.org/10.1039/..

4

Proliferation and ovarian hormone signaling are impaired in..:

Communal, Laudine ; Vilasco, Myriam ; Hugon-Rodin, Justine...
Oncotarget. 7 (2016) 29 - p. 45317-45330 , 2016

Link: https://doi.org/10.18632..

5

Emergence of resistance to tyrosine kinase inhibitors in no..:

Courtin, Aurelie ; Smyth, Tomoko ; Hearn, Keisha...
British Journal of Cancer. 115 (2016) 9 - p. 1069-1077 , 2016

Link: https://doi.org/10.1038/..

6

Anti-Tumour Efficacy of Capecitabine in a Genetically Engin..:

Courtin, Aurélie ; Richards, Frances M. ; Bapiro, Tashinga E....
PLoS ONE. 8 (2013) 6 - p. e67330 , 2013

Link: https://doi.org/10.1371/..

7

Glucocorticoid receptor and breast cancer:

Vilasco, Myriam ; Communal, Laudine ; Mourra, Najat...
Breast Cancer Research and Treatment. 130 (2011) 1 - p. 1-10 , 2011

Link: https://doi.org/10.1007/..

8

Glucocorticoid receptor activity discriminates between prog..:

Courtin, Aurélie ; Communal, Laudine ; Vilasco, Myriam...
Breast Cancer Research and Treatment. 131 (2011) 1 - p. 49-63 , 2011

Link: https://doi.org/10.1007/..

9

Death receptor pathways mediate targeted and non-targeted e..:

Luce, Audrey ; Courtin, Aurélie ; Levalois, Céline...
Carcinogenesis. 30 (2009) 3 - p. 432-439 , 2009

Link: https://doi.org/10.1093/..

10

Progestins induce catalase activities in breast cancer cell..:

Petit, Emile ; Courtin, Aurélie ; Kloosterboer, Helenius J....
The Journal of Steroid Biochemistry and Molecular Biology. 115 (2009) 3-5 - p. 153-160 , 2009

Link: https://doi.org/10.1016/..

11

Quantitation of ERK1/2 inhibitor cellular target occupancie..:

Lebraud, Honorine ; Surova, Olga ; Courtin, Aurélie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253716/. , 2018

Link: http://www.ncbi.nlm.nih...

12

Emergence of resistance to tyrosine kinase inhibitors in no..:

Courtin, Aurelie ; Smyth, Tomoko ; Hearn, Keisha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117788/. , 2016

Link: http://www.ncbi.nlm.nih...

13

Anti-tumour efficacy of capecitabine in a genetically engin..:

Courtin, Aurélie ; Richards, Frances M ; Bapiro, Tashinga E...
https://www.repository.cam.ac.uk/handle/1810/302078. , 2013

Link: https://www.repository.c..

14

Anti-tumour efficacy of capecitabine in a genetically engin..:

Aurélie Courtin ; Frances M Richards ; Tashinga E Bapiro...
http://europepmc.org/articles/PMC3696095?pdf=render. , 2013

Link: https://doi.org/10.1371/..

15

Discovery of ASTX029, A Clinical Candidate Which Modulates ..:

Tom D. Heightman (236769) ; Valerio Berdini (1668088) ; Luke Bevan (2621935)...
https://figshare.com/articles/journal_contribution/Discovery_of_ASTX029_A_Clinical_Candidate_Which_Modulates_the_Phosphorylation_and_Catalytic_Activity_of_ERK1_2/16444618. , 2021

Link: https://doi.org/10.1021/..